Cyclo Therapeutics

YTD

ALL

Why Robinhood?

You can watch CYTH and buy or sell other stocks, ETFs, and their options commission-free!

About CYTH

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease.

CEO

Scott Fine

CEOScott Fine

Employees

—

Employees—

Headquarters

Gainesville, Florida

HeadquartersGainesville, Florida

Founded

1990

Founded1990

Employees

—

Employees—

CYTH Key Statistics

Market cap

23.72M

Market cap23.72M

Price-Earnings ratio

-0.81

Price-Earnings ratio-0.81

Dividend yield

—

Dividend yield—

Average volume

22.85K

Average volume22.85K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.62

52 Week high$1.62

52 Week low

$0.55

52 Week low$0.55

People also own

Based on the portfolios of people who own CYTH. This list is generated using Robinhood data, and it’s not a recommendation.